Philip Adamo, MD, MPH, FACOEM, CIME
Assistant Professor of Medicine
University of Massachusetts Medical School
Associate Vice President and Medical Director
Employee Health Services, Injury Care and Wellness
UMass Memorial Health Care and Medical School
Worcester, Massachusetts

Roy F. Chemaly, MD, MPH, FIDSA, FACP
Professor of Medicine
Director, Infection Control Section
Director of Clinical Virology Research Program
Department of Infectious Diseases, Infection Control & Employee Health
University of Texas MD Anderson Cancer Center
Houston, Texas

Clinical Associate Professor
University of Alabama-Birmingham -
Huntsville Regional Campus
Director, Infection Prevention Department
Huntsville Hospital Health System
Huntsville, Alabama

Saturday, October 10, 2015

5:45 – 8:00 PM
Buffet dinner provided

The San Diego Convention Center
Room 30ABCDE
San Diego, California



If you have any questions leading up to the program or need to cancel,
please contact Daniel McMahon at [email protected].

Target Audience
The target audience of this program is attendees of the IDWeek 2015 Conference.
Specifically, healthcare professionals in infectious diseases and healthcare epidemiology
and prevention, including researchers, clinicians, quality and patient safety practitioners, epidemiologists, and public health officials, including those who see HIV and pediatric patients.

Learning Objectives
Upon completion of this program, participants should be able to:

  1. Differentiate between the 3 available testing methods for LTBI
  2. Identify the clinical utility of IGRAs when testing immunocompromised patients for TB
  3. Determine the epidemiology and incidence of TB and CMV infections in immunocompromised patients
  4. Discuss new data on the role that IGRAs may play in the prediction of CMV infection
  5. Describe the clinical value of IGRAs on preemptive or prophylaxis strategies for CMV
  6. Assess one institution's guidelines for how to handle positive IGRA test results in HCW screening
  7. Discuss case studies demonstrating the importance of screening HCWs for LTBI

Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of CME Outfitters, LLC, and Jespersen & Associates, LLC. CME Outfitters, LLC, is accredited by the ACCME to provide continuing medical education for physicians. CME Outfitters, LLC, designates this live activity for a maximum of 2.0 AMA PRA Category 1 CreditsTM.

Physicians should claim only the credit commensurate with the extent of their participation in the activity. CNE Credit (Nurses): Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 2.0 contact hours.

Commercial Support Statement
This program is supported by an educational grant from Oxford Immunotec.

Please enter the captcha code below.